The NK cell-activating receptor NKG2D plays a critical role in the destruction of malignant cells, but many of the cell-signaling mechanisms governing NKG2D-mediated cellular cytotoxicity are unknown. We have identified an NKG2D-mediated signaling pathway that governs both conjugate formation and cytotoxic granule polarization. We demonstrate that an interaction between the regulatory subunit of PI3K, p85, and the adaptor protein CrkL is required for efficient NKG2D-mediated cellular cytotoxicity. We show decreased NK cell-target cell conjugate formation in NK cells treated with PI3K inhibitors or depleted of CrkL. Independent of adhesion, we find that microtubule organization center polarization toward target cells expressing the NKG2D ligand MICA or toward anti-NKG2D-coated beads is impaired in the absence of CrkL. Ab-stimulated granule release is also impaired in NK cells depleted of CrkL. Furthermore, our data indicate that the small Ras family GTPase Rap1 is activated downstream of NKG2D engagement in a PI3K-and CrkL-dependent manner and is required for conjugate formation, MTOC (microtubule organizing center) polarization, and NKG2D-dependent cellular cytotoxicity. Taken together, our data identify an NKG2D-activated signaling pathway that collectively orchestrates NK cell adhesion, cell polarization, and granule release.
C ytotoxic lymphocytes, such as NK cells and CD8
ϩ T lymphocytes, play a critical role in our body's immune response to malignant and virally infected cells. A principle effector mechanism of cytotoxic lymphocytes is the process of cell-mediated cytotoxicity, during which a target cell is destroyed by a cytotoxic lymphocyte. Cell-mediated cytotoxicity occurs in discrete steps: formation of a cytotoxic lymphocyte-target cell conjugate, polarization of the cytotoxic machinery toward the effector-target cell interface known as the cytotoxic synapse (CS), 3 and finally lytic granule secretion (1, 2) . Although the steps of cytotoxicity have been established, many questions remain regarding the regulation of these steps.
NKG2D is a non-ITAM containing NK-and T cell-activating receptor that recognizes "stress" ligands, such as the tumor-associated MICA (in humans) and Rae-1 (in mice), which are upregulated on the surface of cells undergoing genotoxic stress (3) (4) (5) . Upon NKG2D ligation, the transmembrane protein DAP10 is phosphorylated by the Src kinase Lck (6) . The signal then propagates down two distinct arms of the NKG2D signaling pathway: PI3K and Grb2/Vav1 (4, 7, 8) . Although a number of proteins have been shown to play a role downstream of these proximal signaling molecules, questions remain regarding the signaling pathways regulating NKG2D-mediated conjugate formation, granule polarization, and secretion.
Integrins have been established as regulators of cell adhesion and are required for proper NK cell-target conjugate formation. In fact, blocking ␤ 1 or ␤ 2 integrins inhibits NK cell-mediated cytotoxicity (9) . Moreover, patients with leukocyte adhesion deficiencies display impaired NK cell function (10 -12) . ITAM-containing receptors have been shown to regulate integrins in T lymphocytes, neutrophils, macrophages, and NK cells (13) (14) (15) . Nolz and colleagues established a role for WAVE2 in integrin activation through Abl-and CrkL-C3G-mediated activation of Rap1 in T cell signaling (16) . Vinculin and talin have also been implicated in integrin affinity maturation downstream of the TCR (17) . However, whether signaling pathways activated by NKG2D signaling affect integrin activation or NK cell adhesion is unknown. In fact, two recent reports did not observe any increase in conjugate formation upon stimulation of NKG2D, suggesting that signaling through NKG2D/DAP10 may not activate integrins (8, 18) .
The Crk family of adaptor proteins are a widely expressed family of signal transduction mediators involved in normal and malignant cell processes (19) . This family contains Crk, expressed as two isoforms, CrkI and CrkII, and CrkL (Crk-like) (19) . CrkI has an N-terminal SH2 domain followed by a SH3 domain, whereas both CrkII and CrkL contain an additional C-terminal SH3 domain. These domains serve as binding sites for a number of proteins, allowing Crk proteins to participate in multiple signaling pathways (19) . Recent work has identified CrkL as an important mediator of integrin regulation in T lymphocytes (16) . Although no functional role for CrkL has been demonstrated in NK cells, Crk has been identified as a target following NK inhibitory receptor signaling (20) .
Recombinant vaccinia virus
Wild-type CrkL and Rap1A cDNA were cloned from human NK cell mRNA by RT-PCR. W160Y and W161Y mutations were introduced into the wild-type CrkL cDNA to create the N-terminal SH3 CrkL mutant. The S17A mutation was introduced into wild-type Rap1A cDNA to create a dominant negative (24) . Wild-type and mutant CrkL and Rap1A cDNA were introduced into the pSP11.FLAG vector as previously described (25) . The sequence of wild-type and mutant CrkL and Rap1A vaccinia virus were confirmed. Human NK cells were infected at a multiplicity of infection of 20:1 for CrkL, or 5:1 and 30:1 with F.Rap1A and F.Rap1 S17A, respectively, with appropriate Western Reserve (WR) compensation. Cells were infected for 5 h at 37°C in serum-free media.
Conjugate assays
Human NK clones were stained with PKH26 per included protocol and resuspended at 0.5 ϫ 10 6 cells/ml in RPMI 1640. Target cells were stained with either 50 g/ml 5-sulfofluorescein diacetate (SFDA) (Invitrogen) in PBS for 1 h in a 37°C water bath or 50 M 7-amino-4-chloromethylcoumarin (CMAC) (Invitrogen) for 30 min in serum-free media and then quenched for 15 min in RPMI 1640 plus 10% CS. Target cells were washed twice in PBS and resuspended at 0.5 ϫ 10 6 cells/ml in RPMI 1640. NK cells (0.25 ϫ 10 6 ) were mixed with 0.25 ϫ 10 6 target cells and spun at 500 rpm for 5 min. The resulting pellet was placed in a 37°C water bath for the desired time. Medium (0.5 ml) was removed from each sample after all samples had been heated for the desired amount of time. Samples were then vortexed at maximum speed for 5 s to disrupt nonspecific conjugates and then fixed with 0.5 ml of 4% paraformaldehyde. Conjugate formation was analyzed using a LSRII flow cytotometer (BD Immunocytometry Systems). The SFDA was excited with a 488-nm laser and the emission was measured through a 530/30-nm bandpass (BP) filter. CMAC was excited with a 355-nm laser and the emission was measured through a 450/65-nm BP filter. The PKH26 was excited with a 532-nm laser and the emission was measured through a 575/26-nm BP filter. Data were analyzed with the FlowJo software package (Tree Star). 51 Cr-release assays were performed as previously described (21) . NK cell cytotoxicity was triggered either by coating P815 tumor targets with a "triggering" Ab, such as anti-NKG2D, or by the BaF3 myeloid cell line expressing the NKG2D receptor ligand MICA.
Cytotoxicity assays

GST protein precipitation
GST-CrkL SH2, GST-CrkL SH3-N, and GST-CrkL SH3-C were constructed as previously described (26) . Briefly, 10 ϫ 10 6 human NK clones per sample were stimulated with anti-NKG2D and cross-linked, and then lysed on ice for 10 min with buffer containing 50 mM Tris base, 20 mM EDTA, and 1% Igepal CA-630. Lysates were clarified by centrifugation and transferred to reduced glutathione-agarose coated with 40 g of GST fusion protein. Lysates and beads were rotated at 4°C for 1 h. Protein complexes were eluted with 40 l of SDS sample buffer, resolved by SDS-PAGE, and transferred to Immobilon-P membranes (Millipore). The presence of protein complexes was detected with primary Abs followed by goat anti-mouse-HRP (Santa Cruz Biotechnology) or goat anti-rabbit HRP (Santa Cruz Biotechnology) and visualized with the SuperSignal detection system (Pierce Biotechnology).
Immunofluorescence
Immunofluorescence staining of NK cell-target cell and NK cell-bead conjugates was performed similarly to T cell-B cell conjugate immunofluorescence described previously (16, 27) . Briefly, BaF3 and MICA tumor targets were stained with 50 M CMAC for 30 min in serum-free media then quenched for 15 min in RPMI 1640 plus 10% CS. For NK-bead conjugates, sulfate latex beads (Invitrogen) were coated with 2 g of anti-NKG2D or IgG for 1.5 h while rocking at 37°C. Beads were washed three times in PBS plus 2.5% BSA. NK-target cell conjugates were formed by conjugating human NK clones with either MICA expressing or control BaF3 target cells at an E:T ratio of 2:1. NK-bead conjugates were formed by conjugating human NK clones with Ab-coated sulfate latex beads at an E:T ratio of 1:1. Cells were conjugated by spinning NK and targets or NK and beads at 500 rpm for 5 min at room temperature, incubated at 37°C for 10 min, transferred to poly-L-lysine-coated coverslips, and allowed to settle on coverslips for 4 min at 37°C. Conjugates were washed, fixed with 4% paraformaldehyde, and then permeablized with 0.1% Triton X-100. Conjugates were blocked with PBS containing 1% glycerol, 0.1% gelatin from cold water fish, 5% normal goat serum, 0.1% BSA, and 0.4% azide, and then stained with primary Ab followed by either Alexa Fluor 568 goat anti-mouse (Invitrogen) or Cy5-goat anti-mouse (Zymed Laboratories). Anti-␣-tubulin-FITC was also used for MTOC staining. Actin was stained with Alexa Fluor 488 or rhodamine-phalloidin (Invitrogen). Coverslips were mounted in ProLong Gold (Invitrogen). Fixed conjugates were examined at room temperature on a Zeiss Axiovert 200 with an Axiocam HRC digital camera using a ϫ100/1.4 NA oil-immersion DIC objective or Zeiss LSM 510 scanning confocal microscope using a ϫ100/1.4 NA oilimmersion objective. Image acquisition was done with either the Zeiss Axiovision or LSM software packages. 
Rap1 activation assays
The amount of GTP-bound Rap1 was determined by a RalGDS Rap-binding domain pulldown assay as previously described (28) . Briefly, human NK cells were stimulated with either anti-NKG2D or anti-FcR and crosslinked, then resuspended in buffer containing 50 mM Tris (pH 7.5), 50 mM NaCl, 5 mM MgCl 2 , 10% glycerol, and 0.5% Nonidet P-40 (Igepal CA-630). Cells were immediately spun at 25,000 ϫ g for 5 min at 4°C. Lysates were transferred to reduced glutathione-agarose coated with GST-Ral-Rasbinding domain (RBD). Lysates and beads were rotated at 4°C for 15 min. A portion of the lysates was reserved to determine the total amount of Rap1 in the lysate (input). Proteins were eluted and visualized as previously described (23) . Densitometry was performed using ImageJ (National Institutes of Health), corrected for total Rap1A loading, and then plotted as fold change relative to control baseline.
Secretion assays
Granule secretion was determined in human NK cells as previously described (29) . Briefly, human NK clones were stimulated by in a 96-well plate with wells that had been previously coated with anti-FcR, anti-NKG2D, anti-CD56, or 12-O-tetradecanoylphorbol-13-acetate and ionomycin. After a 4 h incubation at 37°C, supernatants were harvested. The granzyme A activity of the supernatants was then assessed by measuring N-␣-carbobenzoxy-L-lysine-thiobenzyl (BLT)-esterase activity.
Results
NKG2D ligation leads to increased adhesion and recruitment of integrins to the cytotoxic synapse
The importance of NKG2D as an activating receptor of NK cells has been clearly established (4, 26) , but the interplay between integrins and NKG2D-mediated cytotoxicity is unclear, despite the fact that integrins are known to play a critical role in natural cytotoxicity (30) . Two recent reports did not observe any increase in conjugate formation upon stimulation of NKG2D, suggesting that signaling through NKG2D/DAP10 may not activate integrins (8, 18) . To more directly examine whether NKG2D signaling might regulate integrin activation, we determined whether stimulation through NKG2D activates integrins in clonally derived, nontransformed, IL-2-activated human NK cells. Unstimulated NK clones displayed limited adhesion to VCAM-1-or ICAM-1-coated surfaces. In contrast, 30.1 Ϯ 2.5% of NK clones stimulated with antiFcR and 27.2 Ϯ 3.9% of clones stimulated with anti-NKG2D adhered to 0.1 g/well of VCAM-1 compared with 15.8 Ϯ 3.2% of clones treated with an IgG control (Fig. 1A) . Similarly, 21.4 Ϯ 1.5% of NK clones stimulated with anti-FcR and 18.3 Ϯ 2.2% of clones stimulated with anti-NKG2D adhered to 0.1 g/well The conjugates were allowed to adhere to poly-L-lysine-coated coverslips, fixed, and stained with rhodaminephalloidin (orange) and either an anti-␤ 1 or anti-␤ 2 integrin Ab with an Alexa Fluor 647 goat anti-mouse secondary (red) as described in Materials and Methods. ␤ 1 or ␤ 2 integrin recruitment was determined by scoring 100 conjugates per coverslip on three coverslips for integrin recruitment to the CS. D, ␤ 2 integrins are required for NKG2D-mediated conjugate formation and cytotoxicity. Human NK clones were stained with PKH26 and then treated with 1 g/ml anti-LFA-1 blocking Ab (mHm23) and allowed to form conjugates with SFDA-stained MICA or BaF3 target cells. Conjugate formation was determined by two-color flow cytometry. E, Human NK clones were treated with 1 g/ml anti-LFA-1 blocking Ab (mHm23) and used in a cytotoxicity assay against two different models of NKG2D-mediated NK cell killing, P815 tumor targets coated with anti-NKG2D or MICA tumor targets. Data shown are representative of two human NK clones.
ICAM-1 compared with 8.8 Ϯ 0.4% of clones treated with an IgG control (Fig. 1B) . To confirm that these effects were specific to the receptor, and not to nonspecific Ab binding to the FcR expressed on the surface of human NK clones, we examined granule secretion by cross-linking the NK cell surface receptor CD56, which would not be expect to trigger granule release. As expected, ligation of FcR or NKG2D enhanced secretion, whereas ligation of CD56 did not increase secretion, demonstrating that NK cell activation in response to anti-FcR or anti-NKG2D is not a result of nonspecific binding to the NK cell FcR (supplemental Fig. 1) . 4 These results demonstrate that stimulation through either FcR or NKG2D increases ␤ 1 and ␤ 2 integrin-mediated adhesion of human NK cells.
Conjugate and CS formation have been established as critical steps in NK cell-mediated cytotoxicity (31) . Integrin recruitment to the CS has been demonstrated in a K562 tumor target model of natural cytotoxicity, but it has not been examined in primary human NK cells activated by ligation of NKG2D with its natural ligand, MICA (1). BaF3 cells stably expressing MICA were conjugated with NK cells to determine whether integrins are recruited to the CS by NKG2D ligation (Fig. 1C) . ␤ 1 and ␤ 2 integrins localized diffusely within the plasma membrane of isolated NK clones. In NK cells conjugated with wild-type BaF3 cells, ␤ 1 or ␤ 2 integrins did not localize to the CS. However, ␤ 1 integrins were recruited to the NK CS in 48.7 Ϯ 5.5% of NK/MICA conjugates vs 7.7 Ϯ 1.5% in NK/BaF3 conjugates. Similarly, ␤ 2 integrins were recruited to the NK CS in 51 Ϯ 6% of NK/MICA conjugates vs 11 Ϯ 1% in NK/BaF3 conjugates. These data demonstrate that ␤ 1 and ␤ 2 integrins are recruited to the NKG2D-mediated CS.
LFA-1 is required for NKG2D-mediated conjugate formation and cytotoxicity
The role of LFA-1 in NKG2D-mediated cytotoxicity in NK cells has been suggested in previous studies but has not been established in primary human lymphocytes (32, 33) . In this study, we used human NK clones and two models of cytotoxicity, reverse-Abdependent cellular cytotoxicity and MICA-expressing BaF3 cells, to establish a role for the ␤ 2 integrin LFA-1 in NKG2D-triggered NK cell-mediated cytotoxicity. Treatment of NK clones with 1 g/ml of the anti-LFA-1-blocking Ab mHm23 decreased NK cell conjugate formation Ͼ50% compared with IgG control Ab (Fig.  1D ). mHm23 treatment affected cytotoxicity in our reverse-Abdependent cellular cytotoxicity model and caused a significant decrease in the killing of MICA-expressing BaF3 cells (Fig. 1E) . To show that lysis of MICA-expressing BaF3 cells is specific to the ligation of NKG2D, we inhibited NKG2D-mediated NK cell activation with an anti-NKG2D blocking Ab, which confirmed that MICA engagement by NKG2D was required for killing target cells (supplemental Fig. 2) . These results establish a role for LFA-1 in NKG2D-mediated cytotoxicity in primary human NK cells.
PI3K regulates NKG2D-mediated conjugate formation
PI3K has been established as an important signaling mediator in NKG2D-stimulated NK cell cytotoxicity (4). Although Giurisato et al. reported that PI3K did not affect basal conjugate formation in the NK cell tumor line NK92 (18) , this is surprisingly not the case in primary human NK cells. In fact, NK clones treated with the classic PI3K inhibitors wortmannin or LY294002 decreased conjugate formation by Ͼ50% (Fig. 2A) . Cytotoxicity was also substantially decreased in NK clones treated with either PI3K inhibitor. As expected, Akt phosphorylation was decreased with wortmannin treatment (Fig. 2B) . Therefore, in primary human NK clones, PI3K activity regulates NKG2D-mediated conjugate formation and subsequent cytolysis.
NK cell-mediated cytotoxicity is regulated by CrkL
CrkL has been shown to regulate integrins following TCR ligation in T lymphocytes (16) . We therefore examined whether CrkL regulates integrin function in NK cells. CrkL was clearly recruited to the cytotoxic synapse in NK clones conjugated with MICA targets but not in control BaF3 cells (Fig. 3A) . In fact, CrkL was recruited to the NK CS in 33.3 Ϯ 5.0% of NK-MICA conjugates vs 3.3 Ϯ 1.2% in NK-BaF3 conjugates (see Fig. 6A ). The staining of CrkL at the CS was highly similar to the polarized F-actin polymerization seen in NK-MICA cell conjugates. Next, we explored phosphorylation of CrkL in NK cells upon stimulation of NKG2D. Crk family members are initially recruited by activating receptors, but then phosphorylated by Abl tyrosine kinase at an inhibitory residue to terminate signaling. In fact, phosphorylation of CrkL occurs in TCR-mediated signaling regulating integrin activation (16) . Interestingly, Crk was recently shown to be phosphorylated in an Abldependent manner upon ligation of inhibitory killer Ig-related receptors (KIRs) to terminate signaling from activating receptors (20) . Significantly, cross-linking NKG2D on NK clones results in a time-dependent phosphorylation of CrkL, further confirming that CrkL is recruited to NKG2D-dependent signaling pathways (Fig.  3B) . Additionally, to determine the importance of CrkL in NK 4 The online version of this article contains supplemental material. cell-mediated cytotoxicity, we suppressed CrkL in human NK clones with siRNA and used these clones in a cytotoxicity assay against various NK-sensitive targets. CrkL suppression resulted in a significant decrease in cytotoxicity against P815 tumor targets coated with either anti-NKG2D or anti-FcR, and against MICAexpressing BaF3 cells (Fig. 3C) . These results indicate that CrkL mediates NK cell-mediated cytotoxicity triggered by multiple activating receptors, including NKG2D.
Given that integrins are critical to conjugate formation in NK cell-mediated cytotoxicity and the known requirement of CrkL for integrin function in T cells, we suppressed CrkL in human NK cells to explore the role of CrkL in NK-target cell conjugate formation. CrkL suppression in NK clones results in a Ͼ90% decrease in conjugate formation between NK cells and MICA-expressing BaF3 cells compared with NK clones treated with a negative control siRNA (siNeg) (Fig. 4A) , implicating CrkL in NKG2D-mediated cell-cell adhesion.
Our data demonstrate that NKG2D-mediated conjugate formation is both CrkL-and PI3K-dependent. However, it remained possible that suppression of CrkL was affecting global signaling from NKG2D through an unknown mechanism. To examine this, we measured the phosphorylation kinetics of Akt and Erk, two PI3K-regulated pathways (34) , in NK cells suppressed for CrkL. Importantly, treatment of NK cells with CrkL siRNA (siCrkL) did not affect Akt or Erk phosphorylation compared with siNeg-treated controls (Fig. 4B) . Therefore, CrkL suppression does not affect either of these PI3K-dependent pathways. Moreover, NKG2D-dependent tyrosine phosphorylation of Vav1, SLP76, and PLC␥2 are unaffected by suppression of CrkL (C. M. Segovis and D. D. Billadeau, unpublished observation).
CrkL is involved in NKG2D-mediated cell polarization and granule secretion
We next examined secretion in NK cells treated with siCrkL. Surprisingly, siCrkL-treated NK clones displayed decreased secretion when stimulated by either anti-FcR or anti-NKG2D (Fig. 5A ). This effect was observed at multiple Ab concentrations: 30% and 46% decrease at 1 and 0.3 g/ml anti-FcR, respectively, and 84% and 87% decrease at 1 and 0.3 g/ml anti-NKG2D, respectively. 12-O-tetradecanoylphorbol-13-acetate/ionomycin-induced secretion was not affected by CrkL suppression, indicating that granule/ membrane fusion was not affected and thus suggesting a role for CrkL in establishing polarized granule secretion in NK cells.
Microtubule polarization to the CS is required for localized release of granules (35) . We therefore examined MTOC polarization in primary human NK cells treated with CrkL siRNA. CrkL suppression significantly impaired MTOC polarization to the CS of NK-MICA targets compared with NK clones treated with negative control siRNA (Fig. 5B) . Since the loss of MTOC polarization in the siCrkL NK clones could be due to diminished conjugate formation (Fig. 4) , we used anti-NKG2D beads to explore the role of CrkL in integrin-independent MTOC polarization. A 52% decrease in MTOC polarization was observed in NK clones treated with siCrkL in NK-bead conjugates compared with siNeg-treated NK clones (Fig. 5C ). These data demonstrate that CrkL regulates not only conjugate formation, but also MTOC polarization and subsequent granule secretion, all of which are required for NK cellmediated cytotoxicity.
PI3K interacts with the N-terminal SH3 domain of CrkL
PI3K is a critical proximal signaling regulator of NKG2D-mediated NK cell cytotoxicity (4, 36) . Our results indicate that both PI3K activity and CrkL regulate NKG2D-mediated adhesion, suggesting that CrkL may signal downstream of PI3K. To test this, we treated NK clones with wortmannin and determined if CrkL recruitment to the CS was affected. Treatment of human NK clones with wortmannin decreased recruitment of CrkL to the CS of NK-MICA target cell conjugates by 78% (Fig. 6A) . However, we cannot rule out the possibility that this defect in CrkL recruitment is a result of defective conjugate formation in the wortmannin-treated NK cells. Since CrkL has been observed in complex with p85 in NK cells (37), we used immunoprecipitation (IP) to establish an association between CrkL and p85 in our system and to determine The conjugates were allowed to adhere to poly-L-lysine-coated coverslips, fixed, and stained with FITC-phalloidin (green) and an anti-CrkL Ab with an Alexa Fluor 568 goat anti-mouse secondary (red) as described in Materials and Methods. Each treatment group contained three coverslips. Samples were blinded, and 50 conjugates per coverslip were scored for CrkL polarization to the cytotoxic synapse. Bar ϭ 5 M. B, Human NK clones (10 ϫ 10 6 /sample) were stimulated with anti-NKG2D/goat antimouse Abs for 0, 2, or 5 min and then lysed and clarified. Lysates were cleared with IgG-coated agarose and then immunoprecipitated with IgG, anti-CrkL, or anti-p85 followed by SDS-PAGE and immunoblot. C, Human NK clones (10 ϫ 10 6 /sample) were stimulated with anti-NKG2D/goat anti-mouse Abs for 0 or 5 min and then lysed and clarified. Lysates were immunoprecipitated with anti-reduced glutathione coated with GST or GST fusion proteins, followed by SDS-PAGE and immunoblot. D, NK clones were nucleofected with either CrkL or a negative control siRNA. Seventy-two hours after nucleofection, siRNA-treated cells were infected with WR, F.CrkL, or N-terminal SH3 CrkL mutant (SH3-Nmt) vaccinia virus as described in Materials and Methods. These clones were used in a cytotoxicity assay with P815 mouse tumor targets coated with 10 ng/well anti-NKG2D. CrkL expression was determined by SDS-PAGE and immunoblotting of siRNA-treated cell lysates. Results are representative of more than two human NK clones.
whether the interaction was NKG2D induced. Indeed, CrkL coimmunoprecipitated p85 in both unstimulated and NKG2D-stimulated human NK clones, indicating a constitutive interaction between these two molecules (Fig. 6B) . Similarly, an IP of p85 indicated constitutive p85-CrkL association (Fig. 6B ). The N-terminal SH3 domain of CrkII has been shown to interact with the proline-rich region of p85, the regulatory subunit of PI3K, upon TCR activation, and in vitro an interaction has been demonstrated between the SH3 domains of CrkL and p85 (38, 39) . However, which of the two CrkL SH3 domains interacts with p85 is unknown in NK cells. Using GST fusion proteins of individual SH2 and SH3 domains of CrkL, we found that the N-terminal SH3 domain of CrkL bound p85 (Fig. 6C) . We next sought to determine the functional significance of this interaction in NKG2D-mediated cellular cytotoxicity by analyzing whether disruption of this p85-CrkL complex would lead to impaired killing. To test this, we performed siRNA rescue experiments in which wild-type CrkL or an N-terminal SH3 mutant (SH3-Nmt) were overexpressed in human NK clones pretreated with siCrkL. Significantly, overexpression of wild-type CrkL partially rescued the decrease in NKG2D-dependent cytotoxicity seen with CrkL suppression, whereas the CrkL SH3-Nmt was unable to rescue the cytotoxic defect in the CrkL-suppressed cells (Fig. 6D ). These results demonstrate a regulatory role for the N-terminal SH3 domain of CrkL in NKG2D-mediated NK cell cytotoxicity. Taken together, our results demonstrate that p85 and CrkL are in a complex, and that this interaction regulates the development of NKG2D-mediated cytotoxicity in human NK cells.
NKG2D-mediated cytotoxicity is Rap1-dependent
Rap1 has been demonstrated to be critical regulator of integrin activation in T lymphocytes through a CrkL-C3G complex (16), but no role for Rap1 has been established in human NK cells (40, 41) . Ligation of either the FcR or NKG2D results in activation of Rap1 (Fig. 7A) . To confirm these results, we studied the activation of MST1 upon FcR and NKG2D receptor ligation. The Rap1-RAPL-MST1 signaling cascade has been shown to be required for adhesion and cell polarity in lymphocytes in response to chemokine stimulation, and activation of Rap1 results in phosphorylation of MST1 (42) . Ligation of either FcR or NKG2D increased phosphorylation of MST1, supporting the idea that Rap1 is coupled to these activating receptors in NK cells (supplemental Fig. 3 ). Previous work has demonstrated that CrkL regulates the GTP loading and activation of Rap1 downstream of several cell surface receptors (43) (44) (45) . Since Rap1 is activated by NKG2D ligation, we asked if either PI3K activity or CrkL regulates Rap1-GTP loading. In fact, treatment with wortmannin (Fig. 7B) or siRNA depletion of CrkL (Fig. 7C ) abrogated NKG2D-stimulated Rap1 activation. Taken together, these data indicate that Rap1 is activated following FcR and NKG2D ligation in a PI3K-and CrkL-dependent manner.
To determine the role of Rap1 in NKG2D-mediated cytotoxicity in human NK cells, we initially expressed a wild-type or dominantnegative version of Rap1 (S17A) in NK cells and examined NKG2D-mediated killing (24) . In contrast to expression of wildtype Rap1, which did not affect killing through NKG2D, expression of Rap1 S17A inhibited killing of either MICA expressing BaF3 cells or P815 cells coated with anti-NKG2D (Fig. 7D) . Since overexpression of Rap1 S17A may have off-target effects associated with its dominant-negative function, we utilized siRNA to suppress Rap1A and Rap1 B in NK clones, as both Rap1A and Rap1B are expressed in human NK cells (Fig. 7E, immunoblot) . Importantly, suppression of either Rap1A or Rap1B decreased NKG2D-mediated cytotoxicity against multiple tumor targets, which was further diminished by suppression of both Rap1 isoforms (Fig. 7E) .
Given that both PI3K and CrkL regulate NKG2D-dependent Rap1 activation and conjugate formation, we used dominant-negative Rap1A to assess the role of Rap1 in NK-target conjugate Cells were lysed, and the GTP-bound Rap1 was determined by immunoprecipitation with glutathione S-transferase-RalGDS followed by SDS-PAGE and immunoblotting. B, Human NK clones were treated with DMSO or 0.1 M wortmannin and then stimulated with anti-NKG2D/goat anti-mouse Abs for 0, 1, 2, or 5 min. Cells were lysed, and the GTP-bound Rap1 was determined by immunoprecipitation with glutathione S-transferase-RalGDS followed by SDS-PAGE and immunoblotting. C, NK clones were nucleofected with either CrkL or a negative control siRNA. Seventy-two hours after nucleofection, siRNA-treated cells were stimulated with anti-NKG2D/goat anti-mouse Abs for 0, 1, or 5 min. Cells were lysed, and the GTP-bound Rap1 was determined by immunoprecipitation with glutathione S-transferase-RalGDS followed by SDS-PAGE and immunoblotting. Fold change relative to baseline control was calculated using densitometry and corrected for total Rap1A expression. D, NK clones were infected with WR, F.Rap1A, or F.Rap1A S17A vaccinia virus as described in Materials and Methods. Infected cells were used in a cytotoxicity assay with MICA or BaF3 target cells or with P815 mouse tumor targets coated with anti-NKG2D. Overexpression of F.Rap1 and F.Rap1A S17A was determined by SDS-PAGE and immunoblotting. Results are representative of four human NK clones. E, NK clones were nucleofected with Rap1A, Rap1B, or a negative control siRNA. Seventy-two hours after nucleofection, siRNA-treated cells were used in a cytotoxicity assay with MICA or BaF3 target cells or with P815 mouse tumor targets coated with anti-NKG2D. Suppression of Rap1 was determined by SDS-PAGE and immunoblotting of siRNA-treated cell lysates. Results are representative of more than three human NK clones.
formation. Indeed, overexpression of Rap1A had no effect on conjugate formation between NK cells and MICA-expressing BaF3 cells compared with WR-infected cells (Fig. 8A ). In contrast, overexpression of Rap1A S17A significantly decreased conjugate formation between NK cells and MICA-expressing targets equal to conjugate formation between WR-expressing NK clones and BaF3 control targets (Fig. 8A) . We also examined the effect of Rap1A or dominant-negative Rap1 on integrin-independent MTOC polarization in primary human NK cells. Rap1A overexpression did not affect MTOC polarization to the CS of NK-NKG2D-coated bead conjugates compared with WR-infected cells (Fig. 8B) . However, overexpression of dominant-negative Rap1A decreased MTOC polarization by 53% in NK-bead conjugates compared with WRinfected cells (Fig. 8B) . Overall, these results demonstrate that Rap1 activation by NKG2D is PI3K-and CrkL-dependent, and that Rap1 regulates NKG2D-mediated adhesion and MTOC polarization leading to NK cell cytotoxicity.
Discussion
In this paper we describe an NKG2D-mediated signaling pathway for the regulation of conjugate formation, MTOC polarization, and granule secretion. Integrins have been shown to play a critical role in lymphocyte function regulated by ITAM-containing receptors such as the TCR, but little is known about the regulation of integrins by non-ITAM-containing receptors such as NKG2D. We establish that ligation of FcR and NKG2D increase adhesion to ␤ 1 and ␤ 2 integrin ligands VCAM-1 and ICAM-1. Using blocking Abs we have established a role for the ␤ 2 integrin in NKG2D-mediated NK-tumor target formation and cytotoxicity. This is consistent with the observation that patients with leukocyte adhesion deficiencies display impaired NK cell function (10 -12) .
The results presented herein indicate that NKG2D signaling regulates NK cell adhesion and that LFA-1 is required for optimal killing through NKG2D. Surprisingly, previous studies aimed at dissecting NKG2D-mediated signaling in both human and mouse NK cells suggest that neither the PI3K nor Grb2/Vav1 pathways regulate NKG2D-mediated cellular adhesion (8, 18) . Taken at face value, these studies would seem to indicate that neither of the two known signaling pathways engaged by NKG2D is important in stimulating adhesion. However, the amount of conjugate formation between NK cells and NKG2D-sensitive targets in both studies is only slightly, if at all, increased over control targets (8, 18) , suggesting the possibility that NKG2D engagement does not trigger integrin activation, similar to known ITAM-containing receptors. However, our data provide evidence that NKG2D ligation does in fact increase integrin-mediated adhesion to plate-bound substrates, as well as conjugate formation to NKG2D ligand-bearing target cells. Moreover, our data identify PI3K signaling as an important mediator of NKG2D-stimulated adhesion. Thus, our work adds to the understanding of the NKG2D-mediated signaling pathways by establishing that NKG2D-mediated conjugate formation is PI3K-dependent. Future studies will be important to determine whether the Grb2/Vav1 pathway also participates in NKG2D-stimulated adhesion.
The Crk family of adaptor proteins, Crk and CrkL, are important regulators of cell motility and adhesion in multiple cell types and in the regulation of the oncogenic BCR-Abl mutation (19) . The lymphocyte Crk family member, CrkL, has been clearly established as an important adaptor protein in T lymphocyte biology (16) and it has been suggested that CrkL plays a role in NK cell activation, but it has not been established if CrkL plays a role in the activation of NK cells by non-ITAM-containing receptors such as NKG2D (46, 47) . In this study we establish that CrkL regulates NKG2D-mediated NK cell-mediated cytotoxicity, in part through its effects on cell adhesion and establishing cellular polarity. These results are significant since a recent study has shown that engagement of an inhibitory KIR on NK cells results in the inactivation of Crk through Abl-mediated phosphorylation at a known inhibitory site (20) . Interestingly, the KIR-generated inhibitory signal could be overcome by expression of a Crk protein lacking the inhibitory phosphorylation site. Our data implicate CrkL in both ITAM-dependent and ITAM-independent signaling pathways leading to granule release and cellular cytotoxicity. Whether CrkL is phosphorylated by KIR engagement and serves a functionally redundant role with Crk in the regulation of NK cellular cytotoxicity remains to be determined.
PI3K has been shown to regulate cellular polarity and adhesion in multiple cell types (48, 49) . Additionally, the regulatory subunit of PI3K, p85, has also been shown to interact with CrkL in transformed cell lines (38) . These observations are consistent with our study using normal human NK cells, and we add the observation FIGURE 8. Rap1 regulates NKG2D-mediated conjugate formation and MTOC polarization. A, NK clones were infected with WR, F.Rap1A, or F.Rap1A S17A vaccinia virus as described in Materials and Methods. Infected cells were then stained with PKH26 then allowed to form conjugates with CMAC-stained MICA or BaF3 target cells. Conjugate formation was determined by two-color flow cytometry. Overexpression of F.Rap1 and F.Rap1A S17A was determined by SDS-PAGE and immunoblotting. Results are representative of three human NK clones. B, NK clones were infected with WR, F.Rap1A, or F.Rap1A S17A vaccinia virus as described in Materials and Methods. Infected cells were allowed to form conjugates with beads coated with 2 g of IgG or anti-NKG2D. The conjugates were allowed to adhere to poly-L-lysine-coated coverslips, fixed, and stained with FITC-conjugated anti-␣-tubulin (green) as described in Materials and Methods. Three coverslips were prepared per treatment group. One hundred conjugates per coverslip were scored for NK-bead conjugate MTOC polarization. Overexpression of F.Rap1A and F.Rap1S17A was confirmed by immunofluorescence and Western blotting. Results are representative of two human NK clones.
that PI3K interacts with the N-terminal SH3 domain of CrkL in primary human NK clones and that this interaction is important for NKG2D-stimulated killing. Moreover, our data indicate that CrkL is involved in establishing cellular polarity downstream of NKG2D, affecting both MTOC polarization and granule release. Bryceson et al. have indicated that in resting NK cells, granule polarization is integrin regulated whereas degranulation is controlled by FcR ligation (50) . In our study, beads that are coated with only anti-NKG2D stimulate recruitment of the MTOC to the NK-bead interface in a CrkL-dependent manner, suggesting that in IL-2 expanded human NK clones, integrins are not required for MTOC polarization.
How an activation signal passes from NKG2D-PI3K-CrkL to Rap1 remains to be determined. Indeed, PI3K has been shown to regulate Rap1-dependent adhesion (48) . Rap1 is an integral protein involved in the activation of integrins in T cells, where it has also been shown to regulate cell motility and polarity (51, 52) . Recently, Rap1 activation following TCR ligation has been shown to occur via a complex of proteins including CrkL and C3G (16, 53) . Interestingly, although CrkL is required for NKG2D-mediated conjugate formation and cytotoxicity, C3G does not appear to participate in NKG2D-mediated cellular cytotoxicity (supplemental Fig. 4) . Still, our data suggest that Rap1 is activated in a PI3K-and CrkL-dependent manner following NKG2D ligation and mediates NK cell cytotoxicity through regulation of both NKG2D-mediated adhesion and MTOC polarization in human NK cells. Given that C3G suppression does not effect NKG2D-mediated cytotoxicity, it is likely that the NKG2D-PI3K-CrkL signaling cascade signals through another Rap1 activator such as CalDAG-GEF, PDZ-GEF, or DOCK4 (53) . Additionally, the Rap1 effector pathways required for NKG2D-initiated cell killing remain to be determined.
Taken together, we have identified that PI3K activity regulates cell adhesion stimulated through engagement of NKG2D. Moreover, we have shown that the adaptor protein CrkL and the small GTPase Rap1 play important roles downstream of PI3K, controlling not only integrin activation, but also establishing NKG2D-dependent cellular polarity, leading to granule exocytosis and optimal cellular cytotoxicity. A further understanding of the NKG2D-PI3K-CrkL-Rap1 signaling pathway, as well as other signaling pathways engaged by this activating receptor, will likely provide important insight into the causes of leukocyte adhesion deficiencies as well as other disorders of NK cell function.
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